New Genetic Biomarkers for Traumatic Brain Injuries
Author Information
Author(s): Rabou Yasmin Kamal Abd, Zayed Abeer Ahmed, Fahim Sally A., Abdelgwad Marwa, Fiki Ahmed El, Fayed Nermin Nabil
Primary Institution: Cairo University
Hypothesis
Can specific blood-based biomarkers improve the diagnosis and prognosis of traumatic brain injuries?
Conclusion
AKT3, hsa-miR-16-5p, and GSK-3β are effective diagnostic biomarkers for traumatic brain injury, while MALAT-1 is particularly useful for severe cases.
Supporting Evidence
- AKT3 levels increased significantly in TBI patients compared to controls.
- GSK-3β levels decreased over time in TBI patients.
- hsa-miR-16-5p levels were higher in mTBI patients compared to modTBI and sTBI.
- MALAT-1 showed significant increases in severe TBI cases.
- ROC curve analysis indicated excellent diagnostic performance for AKT3, GSK-3β, and hsa-miR-16-5p.
Takeaway
Doctors can use certain blood tests to better understand brain injuries and how serious they are, helping patients get the right care.
Methodology
The study involved a case-control design with blood samples from 30 TBI patients and 10 healthy controls, analyzing specific biomarkers using RT-PCR.
Potential Biases
Potential bias due to the small sample size and the subjective nature of some assessments.
Limitations
The small sample size limited the generalizability of the findings.
Participant Demographics
Participants included 30 TBI patients aged 18-45, with a balanced gender distribution, and 10 healthy controls matched for age and sex.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website